Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19

NCT04932915 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Failure of recruiting patients

Conditions

Covid19

Interventions

DRUG: Niclosamide
DRUG: Placebo

Sponsor

UNION therapeutics